An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

NCT06836232 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Pericarditis

Interventions

DRUG: VTX2735
DRUG: VTX2735
DRUG: VTX2735
DRUG: VTX2735
DRUG: VTX2735

Sponsor

Zomagen Biosciences Ltd.